SLE disease activity index
Increased Tim-3 expression on peripheral T lymphocyte subsets and association with higher disease activity in systemic lupus erythematosus
... with SLE and 28 age- and sex-matched healthy controls ...active SLE, as defined by their score on the SLE Disease Activity Index, had lower proportions of CD3 + CD4 + T cells and ...
9
<p>Activity Disease in SLE Patients Affected IFN-γ in the IGRA Results</p>
... that disease activity affects patients’ immune sta- tus and could interfere with the body’s response towards infection or ...whether disease activity could affect IGRA result must be ...of ...
7
Performance of cytokine models in predicting SLE activity
... mass index; CCL: Chemokine ligand; CXCL: CXC chemokine ligand; ESR: Erythrocyte sedimentation rate; GFR: Glomerular filtration rate; GWAS: Genome-wide association studies; IFN: Interferon; IL: Interleukin; LR: ...
11
<p>Anti-IL-10 antibody in systemic lupus erythematosus</p>
... age, disease duration, physical symptoms, physical findings, laboratory findings, and ...records. SLE disease activity was assessed using the SLE disease activity ...
5
Cognitive impairment, event-related potentials and immunological status in patients with systemic lupus erythematosus
... NP SLE (NPSLE), and was associ- ated with higher disease activity, measured by the SLE Disease Activity Index (SLEDAI), and with a longer duration of central nervous ...
8
Progress in defining clinically meaningful changes for clinical trials in nonrenal manifestations of SLE disease activity
... Erythematosus Disease Area and Severity Index; CLE: Cutaneous lupus erythematosus; CSI: Cognitive Symptoms Inventory; ECLAM: European Consensus Lupus Activity Measure; FACIT-F: Functional Assessment ...
5
Alpha actinin binding antibodies in relation to systemic lupus erythematosus and lupus nephritis
... 1. Disease activity in patients with SLE was determined by the calculation of a Systemic Lupus Erythematosus Disease activity index (SLEDAI), based upon clinical findings in the ...
8
EVALUATION OF SERUM INTERLEUKIN-34, AS A MARKER OF DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS AND RHEUMATOID ARTHRITIS PATIENTS
... of SLE and RA and to assess its role as a biomarker of disease ...with SLE, 29 patients with RA, and 29 healthy control subjects. SLE disease activity was measured by systemic ...
6
The Correlation between Serum Concentration of Vitamin D with Vitamin D Receptor Expression and Disease Activity in Indonesian Patients with Systemic Lupus Erythematosus: Preliminary Study
... with disease activity in SLE patients, and circulating levels of activated vitamin D (1,25(OH)2D) contribute to VDR protein levels and its ...the disease activity in SLE ...15 ...
6
Serum tenascin C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study
... for SLE [20] were recruited from the Institute of Rheumatology, Prague, and prospectively followed according to a prede- fined ...visit, disease activity was assessed using the SLEDAI-2 K [21] and ...
11
A Study on QT Interval in patients with SLE and its Correlation with disease activity and Auto Antibodies.
... the index was modified in 2004. In the new index the number of organ systems were increased to nine with inclusion of ophthalmologic, gastrointestinal & hepatic ...
109
Clinical and MRI remission in patients with nonradiographic axial spondyloarthritis who received long term open label adalimumab treatment: 3 year results of the ABILITY 1 trial
... Methods: Patients received adalimumab 40 mg every other week or placebo for 12 weeks, then open-label adalimumab for up to 144 weeks. Clinical and safety data were collected through 3 years, and MRI data were collected ...
13
Secukinumab provides sustained PASDAS defined remission in psoriatic arthritis and improves health related quality of life in patients achieving remission: 2 year results from the phase III FUTURE 2 study
... end point in the FUTURE 2 study, the cut points re- lated to the different disease activity states were re- cently validated, and this post hoc analysis was generated following the more recently validated ...
11
Effect of certolizumab pegol over 96 weeks of treatment on inflammation of the spine and sacroiliac joints, as measured by MRI, and the association between clinical and MRI outcomes in patients with axial spondyloarthritis
... Patient demographics and characteristics in the imaging set (table 1) were comparable to those of the overall study population at baseline. 15 In the imaging set, there were more men in the r-axSpA group, and patients ...
10
Eligibility criteria for biologic disease modifying antirheumatic drugs in axial spondyloarthritis: going beyond BASDAI
... laboratory: disease duration (years), CRP as continuous (mg/dL), Bath Ankylosing Spondylitis Functional Index (BASFI) and the number of comor- bidities (which included arterial hypertension, dyslip- ...
8
B lymphocyte stimulator (BLyS) isoforms in systemic lupus erythematosus: disease activity correlates better with blood leukocyte BLyS mRNA levels than with plasma BLyS protein levels
... 37 SLE patients who were evaluated on two separate occasions, trends toward correlation were appreciated between changes in the unmodified or modified SLEDAI and changes in full-length BLyS or ∆ BLyS mRNA lev- els ...
12
Value of self performed joint counts in rheumatoid arthritis patients near remission
... of disease activity and disease duration reflecting daily routine ...low disease activity or remission than ...low disease activity states are now the treatment targets in ...
9
New onset non infectious pulmonary manifestations among patients with systemic lupus erythematosus in Sweden
... with SLE who together with their matched comparators from the general popu- lation could be followed with minimal ...another disease, nor selects “healthy” individuals, both of which would distort the ...
6
Psychometric properties of the painDETECT questionnaire in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: Rasch analysis and test-retest reliability
... the standardised residuals was performed and the item and person goodness-of-fit statistics were exam- ined [38, 39]. When analysing goodness of fit, under- fit and overfit to the Rasch model were evaluated to identify ...
12
Response to Tumor Necrosis Factor Inhibition in Male and Female Patients with Ankylosing Spondylitis: Data from a Swiss Cohort
... phenotype that have been demonstrated between men and women comprise more severe spinal radiographic changes in men, while female patients present with more peripheral arthritis, self-reported disease ...
21